jp morgan glp 1 JPMorgan Predicts 45% Rally for New GLP-1 Market Entrant Unpacking the GLP-1 Hype

Understanding Reasonable Expectations When prescribed as part of a comprehensive program, GLP-1 receptor agonist medications can support significant improvements in health markers and body composition for appropriate candidates

doi: 10.1590/1519-6984.233173

The healthcare costs associated with obesityexceeding $173 billion annually according to CDC datacreate economic burden extending far beyond individual health outcomes

The study in Molecular Nutrition and Food Research demonstrated that nicotinamide supplementation in mice on a high-fat diet reduced body weight gain, increased energy expenditure, and upregulated genes involved in thermogenesis and fat oxidation, including PPARalpha and PGC1alpha